National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool
about
Drug assessment by a Pharmacy and Therapeutics committee: from drug selection criteria to use in clinical practice.A benefit-risk assessment model for statins using multicriteria decision analysis based on a discrete choice experiment in Korean patients.An Annual Formulary Review Strategy Implemented by a Saudi Health System.Quantitative benefit-risk assessment by MCDA of the quadrivalent HPV vaccine for preventing anal cancer in males.Method Development for Clinical Comprehensive Evaluation of Pediatric Drugs Based on Multi-Criteria Decision Analysis: Application to Inhaled Corticosteroids for Children with Asthma.Incorporating MCDA into HTA: challenges and potential solutions, with a focus on lower income settings
P2860
National Drug Formulary review of statin therapeutic group using the multiattribute scoring tool
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 04 December 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
National Drug Formulary review ...... he multiattribute scoring tool
@en
National Drug Formulary review ...... e multiattribute scoring tool.
@nl
type
label
National Drug Formulary review ...... he multiattribute scoring tool
@en
National Drug Formulary review ...... e multiattribute scoring tool.
@nl
prefLabel
National Drug Formulary review ...... he multiattribute scoring tool
@en
National Drug Formulary review ...... e multiattribute scoring tool.
@nl
P2093
P2860
P356
P1476
National Drug Formulary review ...... he multiattribute scoring tool
@en
P2093
Azuana Ramli
Faridah Aryani Md Yusof
Saperi Sulong
P2860
P304
P356
10.2147/TCRM.S52078
P50
P577
2013-12-04T00:00:00Z